Witty
GSK to make ‘fundamental changes’
February 6, 2014Sales and Marketing China, GSK, Tafinlar, Witty, q4, results
GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …
China ban for corrupt pharma firms
January 2, 2014Medical Communications, Sales and Marketing Cameron, China, GSK, Witty, bribery, lilly
GSK changes sales tactics
December 17, 2013Medical Communications, Sales and Marketing GSK, Witty, bribery, corruption, cuts, sales, transparency
GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products. The UK …
Witty goes to China
December 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, Witty, bribery
GlaxoSmithKline chief executive Sir Andrew Witty has embarked on a potentially delicate diplomatic mission as part of a UK trade …
Actions in China ‘shameful’ says GSK boss
July 25, 2013Medical Communications, Sales and Marketing China, GSK, Witty, bribery
GlaxoSmithKline has admitted that allegations of corruption at its China business are ‘shameful’ and will seek out its cause. Speaking …
GSK sales up – impact of China allegations to follow
July 24, 2013Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency
GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …
Sanofi chief executive to lead EFPIA
June 26, 2013Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty
Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …
GSK’s Witty: ‘Drugs should be cheaper’
March 15, 2013Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty
Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …
GSK plans greater use of biocatalysis, continuous processing
February 19, 2013Manufacturing and Production GSK, Witty, biocatalysis
GlaxoSmithKline says it is turning to technology to help improve the cost efficiency of its manufacturing operations, including greater use …
GlaxoSmithKline announces Board changes
September 27, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty
GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …
GSK falters in Q2 as austerity measures bite
July 25, 2012Sales and Marketing Benylsta, GSK, Q2, Seretide, Witty
GlaxoSmithKline posted a loss in its second quarter results, as pressure in mature markets continues to affect the firm. Pharmaceutical …
GSK to pay ‘unprecedented’ $3 billion fraud charge
July 3, 2012Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty
GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …
Witty warns EU leaders over pricing
June 27, 2012Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing
Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …
Europe’s pharma sector : living through the crisis
March 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma
Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …
GSK posts strong underlying sales growth
February 8, 2012Research and Development, Sales and Marketing Avodart, GSK, R&D, Seretide, Witty, rotarix
GlaxoSmithKline has posted strong underlying growth for 2011, but warns of a tough year ahead. The UK firm saw 4% …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
